Viewing Study NCT00055757


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-07-19 @ 2:19 AM
Study NCT ID: NCT00055757
Status: COMPLETED
Last Update Posted: 2013-06-04
First Post: 2003-03-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IIIB Non-small Cell Lung Cancer View
None Stage IV Non-small Cell Lung Cancer View
Keywords: